An Open Label, Phase 1b, Ascending Dose Study of DM199

Completed

Phase 1 Results N/A

Update History

28 Apr '17
The gender criteria for eligibility was updated to "All."
A location was updated in Perth.
New
The overall status was removed for Linear Clinical Research.